News & Insights
Sort By
Client News 13 Results
Client News
|July 24, 2024
Gunderson Dettmer Client JenaValve Enters Agreement to be Acquired by Edwards Lifesciences
Pioneer in the transcatheter treatment of aortic regurgitation (AR), JenaValve Technology, announces its agreement to be acquired by Edwards Lifesciences
Client News
|July 11, 2024
Element Biosciences Announces $277M Series D
Developer of pioneering technologies to empower science, Element Biosciences, announces its $277 million Series D financing led by Wellington Management
Client News
|April 5, 2024
Contineum Therapeutics Announces Initial Public Offering
Clinical stage biopharmaceutical company, Contineum Therapeutics, announces the pricing of its initial public offering of 6,875,000 shares of its Class A common stock at a price to the public of $16.00 per share.